Chemed Corp (CHE)

Chemed’s third quarter saw positive market reaction, with results surpassing Wall Street’s revenue and non-GAAP profit expectations. Management attributed th...

Healthcare services company Chemed Corporation (NYSE:CHE) announced better-than-expected revenue in Q3 2026, with sales up 10.6% year on year to $690.9 milli...

Chemed (NYSE:CHE) reported higher third-quarter revenue and adjusted earnings as growth at its VITAS hospice business offset margin pressure at Roto-Rooter from customer-acquisition and fuel costs. President and Chief Executive Officer Kevin McNamara said consolidated revenue increased 10.6% from t

VITAS revenue surged 12.2% while Roto-Rooter margins compressed from higher costs.

Healthcare services company Chemed Corporation (NYSE:CHE) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 10.6% year on...

Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results this Tuesday after market close. Here’s what investors should know. Cheme...

Looking back on senior health, home health & hospice stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) an...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

Over the past six months, Chemed has been a great trade, beating the S&P 500 by 11.9%. Its stock price has climbed to $493.23, representing a healthy 26.2% i...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

The insider sold 1,000 shares but still holds nearly 14,000 shares.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Chemed’s Q2 results exceeded Wall Street’s expectations, prompting a positive response from investors. Management attributed the performance primarily to str...

Chemed (NYSE:CHE) reported second-quarter 2026 results marked by stronger-than-expected performance at its VITAS hospice business, while Roto-Rooter delivered revenue growth but continued to face higher customer-acquisition costs. President and Chief Executive Officer Kevin McNamara said consolidat

Healthcare services company Chemed Corporation (NYSE:CHE) announced better-than-expected revenue in Q2 CY2026, with sales up 8.8% year on year to $673.3 mill...

Healthcare services company Chemed Corporation (NYSE:CHE) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8.8% year on year ...

Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting earnings this Tuesday after market close. Here’s what to look for. Chemed beat an...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Chemed trades at $513.71 and has moved in lockstep with the market. Its shares have returned 13.3% over the last six months while the S&P 500 has gained 8.4%...

Looking back on senior health, home health & hospice stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) an...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...